Company Updates

Aurora Labs has moved on to develop a larger scale metal printer that was 100X faster than any other machines in the market. Companies including the likes of NASA showed interest in the machine.

The US Food and Drug Administration (FDA) has approved Actinogen Medicals Investigational New Drug (IND) application to recruit for the XanADu, Phase II for the clinical trial of Xanamem™.

US Residential Fund (USR) is pleased to announce the sale of 28 single family houses in Atlanta, Georgia. These specific properties were sold for US$3.95 million consistent with fair value.

The Room Xchange is challenging Australia’s housing affordability crisis.

The company has just released their Half Year Report for 2017 with expectation for the upcoming reporting season to be the highest they have been in three years.

Omni Market Tide Limited (OMT) advises that Mr Paul Fredericks has replaced Mr Paul Cochrane as the Chief Financial Officer and Company Secretary as of February 6, 2017.

PILL has finalised the first phase of a targeted capital raising by placement of 6m shares at $0.24 to raise $1.44m. The oversubscribed “Placement” raised $1.44 million.

Aeeris have said that the Company is set for a year of growth and improved performance for 2017.

Real Estate Investar is proud to announce that they have increased their member base to 250, 124 at the end of the December quarter for 2016, meaning that they achieved its initial public offer (IPO)